Search results for "microbiome"

showing 10 items of 395 documents

Microbial Diversity in the Midguts of Field and Lab-Reared Populations of the European Corn Borer Ostrinia nubilalis

2011

Background: Insects are associated with microorganisms that contribute to the digestion and processing of nutrients. The European Corn Borer (ECB) is a moth present world-wide, causing severe economical damage as a pest on corn and other crops. In the present work, we give a detailed view of the complexity of the microorganisms forming the ECB midgut microbiota with the objective of comparing the biodiversity of the midgut-associated microbiota and explore their potential as a source of genes and enzymes with biotechnological applications. Methodological/Principal Findings: A high-throughput sequencing approach has been used to identify bacterial species, genes and metabolic pathways, parti…

Bacterium identificationEuropean corn borerMicrobial diversityEuropean corn borerStaphylococcusBiodiversityOstrinia nubilalisNegibacteriaMothsAnimal tissueOstriniaMidgutMicrobial population dynamicsBacteria (microorganisms)PhylogenyMultidisciplinaryIntestine floraEcologybiologyBacterial geneSystems BiologyQRHexapodafood and beveragesAgricultureGenomicsLepidopteraPosibacteriaMAQUINAS Y MOTORES TERMICOSMedicineSynthetic BiologySequence AnalysisResearch ArticleBiotechnologyScienceBiological Data ManagementBacterial genomeMicrobiologydigestive systemZea maysArticleLepidoptera genitaliaMetabolic NetworksGeneticsAnimalsMicrobiomeBiologyWeissella paramesenteroidesBacteriabusiness.industryfungiStaphylococcus warneriComputational BiologyMidgutPopulation abundancebiology.organism_classificationNonhumanBiotechnologyAgronomyMetagenomicsWeissellaFISICA APLICADAMetagenomePEST analysisbusinessControlled studyAgroecology
researchProduct

The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease

2018

Commensal gut microbiota have recently been implicated in cardiovascular disease (CVD) and cerebrovascular disease. Atherosclerotic plaque formation depends on the colonization status of the host. In addition to host nutrition and the related microbiota-dependent metabolic changes, activation of innate immune pathways triggers the development of atherosclerosis and supports arterial thrombosis. Gnotobiotic mouse models have uncovered that activation of Toll-like receptor-2 by gut microbial ligands supports von Willebrand factor-integrin mediated platelet deposition to the site of vascular injury. Depending on nutritional factors, the microbiota-derived choline-metabolite trimethylamine N-ox…

Blood Platelets0301 basic medicineIntegrinsEmerging riskImmunologyDiseaseBiologyGut floradigestive systemMethylaminesMice03 medical and health sciencesVon willebrandRisk Factorsvon Willebrand FactormedicineAnimalsHumansImmunology and AllergyPlateletSymbiosisInnate immune systemInfant NewbornInfantThrombosisAtherosclerosisbiology.organism_classificationmedicine.diseaseThrombosisImmunity InnatePlaque AtheroscleroticToll-Like Receptor 2Gastrointestinal MicrobiomeCerebrovascular Disorders030104 developmental biologyCardiovascular DiseasesArterial thrombusImmunologyEuropean Journal of Immunology
researchProduct

The Gut Microbiota as an Influencing Factor of Arterial Thrombosis

2018

The mutualistic gut microbiota does not only impact the development and function of various immune cell types, but it also influences the function of the hepatic vascular endothelium and prothrombotic platelet function. With germ-free mouse models, we have demonstrated that gut-derived microbial-associated molecular patterns could stimulate hepatic von Willebrand factor (VWF) synthesis and plasmatic VWF levels through Toll-like receptor-2 (TLR2), thus defining the extent of platelet deposition to the subendothelial matrix of the ligation-injured common carotid artery. In addition to the microbiota-derived choline metabolite trimethylamine N-oxide and the microbiota's regulatory role on the …

Blood Platelets030204 cardiovascular system & hematologyGut floradigestive system03 medical and health sciences0302 clinical medicineImmune systemVon Willebrand factorAnimalsHumansPlateletInnate immune systembiologyEndothelial CellsThrombosisArteriesHematologybiology.organism_classificationGastrointestinal MicrobiomeTLR2CoagulationImmunologybiology.proteinSignal transductionSignal Transduction030215 immunologyHämostaseologie
researchProduct

LSC Abstract – Functional metagenomics of respiratoy microbiome in exacerbated COPD

2015

Background: The course of COPD is frequently aggravated by exacerbations. New molecular techniques have suggested that many bacterial groups, not only the common COPD pathogens, could trigger the exacerbations. Objective: to analyze the microbial community and the gene content of samples obtained during stability and exacerbation of COPD patients. Method: 16S rRNA was pyrosequenced to obtain the taxonomic information. The metabolic information was obtained with the Metagenomics RAST server (MG-RAST) with KEGG database. Results: 8 severe COPD patients were included. At genus level, 68 different OTUs were found. No significant differences in the relative abundance of any of the detected gener…

COPDExacerbationCatabolismMetagenomicsImmunologymedicineMicrobiomeKEGGBiologyCarbohydrate metabolismmedicine.diseaseBioinformaticsRelative species abundance10.1 Respiratory Infections
researchProduct

Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens.

2021

Abstract Objectives Oral microbiome plays an important role in oral diseases. Among them, proliferative verrucous leucoplakia (PVL) is an uncommon form of progressive multifocal leukoplakia with a worryingly rate of malignant transformation. Here, we aimed to characterize the oral microbiome of PVL patients and compare it with those of healthy controls. Material and methods Oral biopsies from ten PVL patients and five healthy individuals were obtained and used to compare their microbial communities. The sequence of the V3-V4 region of 16S rRNA gene was used as the taxonomic basis to estimate and analyze the composition and diversity of bacterial populations present in the samples. Results O…

Cancer ResearchBiopsymedicine.disease_causeCampylobacter jejuniRNA Ribosomal 16SmedicineProliferative verrucous leukoplakiaHumansEubacteriumLeukoplakiaMouthbiologyCampylobacterMicrobiotabiochemical phenomena metabolism and nutritionrespiratory systembacterial infections and mycosesbiology.organism_classificationmedicine.disease16S ribosomal RNAstomatognathic diseasesCell Transformation NeoplasticOncologyImmunologyOral MicrobiomeOral SurgeryLeukoplakia OralDysbiosisOral oncology
researchProduct

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial : Planned 10-Year Follow-up

2022

Abstract The CAPP2 trial investigated the long-term effects of aspirin and resistant starch on cancer incidence in patients with Lynch syndrome (LS). Participants with LS were randomized double-blind to 30 g resistant starch (RS) daily or placebo for up to 4 years. We present long-term cancer outcomes based on the planned 10-year follow-up from recruitment, supplemented by National Cancer Registry data to 20 years in England, Wales, and Finland. Overall, 463 participants received RS and 455 participants received placebo. After up to 20 years follow-up, there was no difference in colorectal cancer incidence (n = 52 diagnosed with colorectal cancer among those randomized to RS against n = 53…

Cancer ResearchLIVER3122 CancerstärkkelysCOLORECTAL-CANCERBUTYRATESDG 3 - Good Health and Well-beingasetyylisalisyylihappoHumansLynchin oireyhtymäpaksusuolisyöpäRISKIncidenceCOLON-CANCERResistant StarchColorectal Neoplasms/drug therapyCONSUMPTIONColorectal Neoplasms Hereditary NonpolyposisASPIRINMICROBIOMEOncologyAspirin/therapeutic useCELLSDIETARY FIBER INTAKE/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingsyöpätauditennaltaehkäisyseurantatutkimusColorectal Neoplasms Hereditary Nonpolyposis/complicationsColorectal NeoplasmsilmaantuvuusFollow-Up Studies
researchProduct

Identification of Patulin from Penicillium coprobium as a Toxin for Enteric Neurons

2019

The identification and characterization of fungal commensals of the human gut (the mycobiota) is ongoing, and the effects of their various secondary metabolites on the health and disease of the host is a matter of current research. While the neurons of the central nervous system might be affected indirectly by compounds from gut microorganisms, the largest peripheral neuronal network (the enteric nervous system) is located within the gut and is exposed directly to such metabolites. We analyzed 320 fungal extracts and their effect on the viability of a human neuronal cell line (SH-SY5Y), as well as their effects on the viability and functionality of the most effective compound on primary ent…

Central nervous systemPharmaceutical SciencemicrobiomeBiologymedicine.disease_causeAnalytical ChemistryMicrobiologyPatulinlcsh:QD241-44103 medical and health sciencesPolyketidechemistry.chemical_compound0404 agricultural biotechnologyenteric nervous systemlcsh:Organic chemistrymycotoxinsDrug DiscoverymedicineMicrobiomePhysical and Theoretical Chemistryfusarium030304 developmental biologyCalcium signaling0303 health sciencesToxinOrganic Chemistry04 agricultural and veterinary sciences040401 food science<i>Penicillium</i>medicine.anatomical_structurechemistryChemistry (miscellaneous)Cell cultureMolecular Medicinegastrointestinal systemEnteric nervous systemfungiMolecules
researchProduct

Yeast β-glucans and microalgal extracts modulate the immune response and gut microbiome in Senegalese sole (Solea senegalensis)

2019

One bottleneck to sustainability of fish aquaculture is the control of infectious diseases. Current trends include the preventive application of immunostimulants and prebiotics such as polysaccharides. The present study investigated how yeast β-glucan (Y), microalgal polysaccharide-enriched extracts (MAe) and whole Phaeodactylum tricornutum cells (MA) modulated the gut microbiome and stimulated the immune system in Senegalese sole (Solea senegalensis) when administered by oral intubation. Blood, intestine and spleen samples were taken at 3 h, 24 h, 48 h and 7 days after treatment. The short-term response (within 48 h after treatment) consisted of up-regulation of il1b and irf7 expression in…

Chemokinebeta-GlucansRandom allocationSpleenAquatic ScienceMicrobiologyRandom Allocation03 medical and health scienceschemistry.chemical_compoundImmune systemYeast DriedmedicineMicroalgaeBeta-GlucansEnvironmental ChemistryAnimals14. Life underwaterMicrobiomeGastrointestinal microbiome030304 developmental biology2. Zero hungerDiatoms0303 health sciencesbiologyImmunity04 agricultural and veterinary sciencesGeneral Medicinebiology.organism_classificationAnimal FeedImmunity InnateVibrioYeastYeastGastrointestinal MicrobiomeDietmedicine.anatomical_structurePrebioticschemistry040102 fisheriesbiology.proteinFlatfishes0401 agriculture forestry and fisheriesLysozymeBacteria
researchProduct

Digestive disorders and Intestinal microbiota

2018

In the last decade, a barge body of scientific literature has suggested that specific alterations of the gut microbiota may be associated with ther development and clinical course of several gastrointestinal diseases, including irritable bowel syndrome, inflammatory bowel disease, celiac disease, gastrointestinal cancer and Clostridium difficile infection. These alterations are often referred to as “dysbiosis”, a generic term designing reduction of gut microbiota biodiversity and alterations in its composition. Here, we provide a synthetic overview of the key concepts on the relationship between intestinal microbiota and gastrointestinal diseases, focusing on the translation of these concep…

Clostridioides difficileDigestive System DiseasesLiver DiseasesIBDmicrobiomeReviewdysbiosisClostridium difficileBiodiversityDigestive System NeoplasmsInflammatory Bowel Diseasesdigestive systemGastrointestinal MicrobiomeEndotoxinsIrritable Bowel SyndromeCeliac DiseaseIntestinal AbsorptionClostridium InfectionsHumansDisease SusceptibilityActa bio-medica : Atenei Parmensis
researchProduct

Investigating the in vitro catabolic fate of Enniatin B in a human gastrointestinal and colonic model

2019

Abstract Enniatin B is an emerging mycotoxin known to present biological activity because of its ionophoric characteristics. This compound has demonstrated strong in vitro cytotoxicity against different cancer cells, also at low molecular concentrations. Its natural occurrence in food commodities and feed is highly reported world-wide, but few information is available about its stability in the human gastro-intestinal tract. The present work evaluates the catabolic fate of enniatin B upon in vitro simulated digestion and colonic fermentation. LC-MS target and untargeted analysis have been performed to quantify the extent of enniatin B degradation and the formation of catabolic products. The…

ColonIn silicoToxicologyModels BiologicalFeces03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyDepsipeptidesHumansMycotoxin030304 developmental biologyDepsipeptide0303 health sciencesGastrointestinal tractCatabolismBiological activity04 agricultural and veterinary sciencesGeneral MedicineMycotoxins040401 food scienceIn vitroGastrointestinal MicrobiomeGastrointestinal TractchemistryBiochemistryFermentationDigestionFood ScienceFood and Chemical Toxicology
researchProduct